Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke.

[1]  L. Lisabeth,et al.  A population-based study of acute stroke and TIA diagnosis , 2004, Neurology.

[2]  E. Jauch.  Society for Academic Emergency Medicine (SAEM) Neurologic Emergencies Interest Group response to the SAEM Board position on optimizing care of the stroke patient. , 2004, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[3]  Robyn Tamblyn,et al.  Physician and Practice Characteristics Associated with the Early Utilization of New Prescription Drugs , 2003, Medical care.

[4]  M. Hammer,et al.  Quality Improvement and Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Cleveland Update , 2003, Stroke.

[5]  J. Concato,et al.  Thrombolysis for acute stroke in routine clinical practice. , 2002, Archives of internal medicine.

[6]  S. Cramer,et al.  Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals , 2001, Stroke.

[7]  Andrew N. Brown,et al.  Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers: The Influence of Ethnicity , 2001, Stroke.

[8]  J. Byer,et al.  Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke? , 2000, Neurology.

[9]  A. Furlan,et al.  Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. , 2000, JAMA.

[10]  J. Milbrandt,et al.  Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. , 2000, Stroke.

[11]  M. Heller,et al.  Thrombolytics and stroke: what do emergency medicine residents perceive? , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[12]  D. Tanné,et al.  Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey , 1999, Neurology.

[13]  J. Grotta,et al.  Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. , 1998, Stroke.

[14]  J. Escarce,et al.  Externalities in hospitals and physician adoption of a new surgical technology: an exploratory analysis. , 1996, Journal of health economics.

[15]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[16]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[17]  J. Broderick,et al.  Emergency physicians. Accuracy in the diagnosis of stroke. , 1995, Stroke.

[18]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.